<p>Dr. Pandey is an Associate Professor of Cardiology in Internal Medicine at the University of Texas (UT) Southwestern Medical Center, Dallas, Texas. He completed his medical school training at the All India Institute of Medical Sciences in New Delhi, India, followed by an internal medicine residency and a cardiology fellowship at UT Southwestern Medical Center. His clinical interests include the management of heart failure (HF) with preserved ejection fraction (HFpEF), and he is the Medical Director of the HFpEF program at UT Southwestern. As a physician-investigator, he is the principal investigator of the Cardiometabolic Research Unit at UT Southwestern, where he leads an independent research program funded by the NIH, AHA, and industry grants, focused on developing novel approaches to improve cardiometabolic health. Dr. Pandey has extensive experience with clinical trials, prospective observational studies, cardiovascular registries, and big-data approaches to risk prediction. His primary research interest is the management of HFpEF in older adults using novel pharmacologic and lifestyle strategies. He has received numerous research grants from the National Institute of Health, the American Heart Association, and other sponsors for his research focused on the prevention and management of HF. He has published over 450 peer-reviewed manuscripts in leading journals such as NEJM, JAMA, Circulation, JAMA Cardiology, and JACC, among others. He has also received numerous research awards and has served as an author on multiple white papers and position statements from international societies.</p>